McKesson stock holds firm after $105.38 billion quarter

McKesson stock is steady after a June 30, 2026 quarter with $105.38 billion in revenue and $9.93 in EPS, while analysts kept price targets active.

McKesson Corporation (US58155Q1031) is trading with a market value of $99.51 billion after a June 30, 2026 quarter that brought $105.38 billion in revenue and $9.93 in EPS. The shares opened at $853.53 on August 20, 2026, and the stock's 52-week range runs from $673.38 to $999.00.

On August 20, 2026, Royal Bank of Canada upgraded McKesson to Hold, while the same coverage set shows a consensus target of $973.44 and a buy-and-hold split of 14 Buy ratings and 4 Hold ratings. That puts the latest close in a clear gap versus the average target, even after the post-earnings move earlier this month.

Quarterly numbers stay heavy

The latest quarter ended June 30, 2026 and came with revenue up 7.7% year over year, from $97.83 billion to $105.38 billion. EPS also improved from $8.26 a year earlier to $9.93, and net margin stood at 1.12%.

Analysts on August 20, 2026 were still looking for $44.65 in earnings per share for the current fiscal year, and one coverage update said McKesson's FY 2027 guidance is $44.200 to $45.000 EPS. The contrast between current-quarter execution and the full-year view is the main valuation question.

What the chart says

McKesson stock opened at $853.53 on August 20, 2026, above its 50-day average of $818.34 and slightly above its 200-day average of $843.66. The stock also sits below the $999.00 52-week high, leaving room for traders to weigh momentum against the recent earnings release.

For investors, the important detail is that the market cap of $99.51 billion already reflects a business that keeps producing quarterly sales above $100 billion. That makes the next stretch of trading more about whether earnings can keep pace with the revenue base.

Pharmacy distribution scale

McKesson's core business remains pharmaceutical distribution and healthcare supply services, with the latest quarter showing how scale still matters when revenue reaches $105.38 billion. The business mix also explains why small changes in margin can still move EPS sharply from quarter to quarter.

Stock level

McKesson stock opened at $853.53 on August 20, 2026, with a $99.51 billion market cap and a 52-week range of $673.38 to $999.00.

Fact box

Company: McKesson Corporation

ISIN: US58155Q1031

Ticker: MCK

Exchange: NYSE

Sector / Industry: Health Care / Healthcare Distributors

Index membership: S&P 500

Price (as of August 20, 2026): $853.53 USD

Market cap: $99.51 billion

Next earnings date: October 29, 2026